SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease

被引：6
作者：
Dimopoulos, Christina [1 ]
Al-Bawardy, Badr [2 ]
机构：
[1] Yale Univ, Dept Internal Med, New Haven, CT USA
[2] Yale Univ, Yale Sch Med, Sect Digest Dis, New Haven, CT USA
来源：
INFLAMMATORY BOWEL DISEASES | 2020年 / 26卷 / 12期
关键词：
Crohn's disease; SARS-CoV-2; biologic;
D O I：
10.1093/ibd/izaa275
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E153 / E154
页数：2
相关论文
共 3 条
  • [1] Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
    Brenner, Erica J.
    Ungaro, Ryan C.
    Gearry, Richard B.
    Kaplan, Gilaad G.
    Kissous-Hunt, Michele
    Lewis, James D.
    Ng, Siew C.
    Rahier, Jean-Francois
    Reinisch, Walter
    Ruemmele, Frank M.
    Steinwurz, Flavio
    Underwood, Fox E.
    Zhang, Xian
    Colombel, Jean-Frederic
    Kappelman, Michael D.
    [J]. GASTROENTEROLOGY, 2020, 159 (02) : 481 - +
  • [2] Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center
    Kwapisz, Lukasz
    Raffals, Laura E.
    Bruining, David H.
    Pardi, Darrell S.
    Tremaine, William J.
    Kane, Sunanda V.
    Papadakis, Konstantinos A.
    Coelho-Prabhu, Nayantara
    Kisiel, John B.
    Heron, Valerie
    Faubion, William A.
    Loftus, Edward V., Jr.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (03) : 616 - 617
  • [3] Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease
    Yang, Edward
    Panaccione, Nicola
    Whitmire, Natalie
    Dulai, Parambir S.
    Vande Casteele, Niels
    Singh, Siddharth
    Boland, Brigid S.
    Collins, Angelina
    Sandborn, William J.
    Panaccione, Remo
    Battat, Robert
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1031 - 1038
1